A study to improve knowledge and attitude regarding HPV infection, cervical cancer and its vaccination among undergraduate students in Government Medical College, Almora, Uttarakhand: An Educational intervention
Abstract
Background and Aim: Human papillomavirus (HPV) is the most common sexually transmitted infection and a primary cause of
cervical cancer in women. Although incurable, HPV infection can be largely prevented through timely vaccination. This study aims
to explore the basic understanding of medical students about cervical cancer, HPV and HPV vaccination.
Methods: This was a descriptive, questionnaire based cross‑sectional study conducted among the undergraduate medical students from
March 2025 to May 2025. A total of 380 respondents participated in the study and SPSS Version 29.0.2.0 was used to analyse the data.
Results : A total of 380 students attended four educational lectures on human papillomavirus (HPV), cervical cancer, and the HPV
vaccine and completed pre- and post-tests. Most participants were younger than 21 years (56.6%), with nearly equal representation of
males and females. Post-test results showed improved knowledge regarding HPV and cervical cancer, particularly about risk factors
and preventive measures. Knowledge of the HPV vaccine also increased, especially regarding the recommended age of vaccination
in India and required doses. Participants additionally demonstrated more positive attitudes toward HPV vaccination, including greater
acceptance among sexually active females and increased recognition of HPV infection as a public health concern.
Conclusion: This study suggests that including material on HPV vaccination in the standard medical student curriculum could help
increase physician recommendation for the HPV vaccine.
References
Sreedevi A, Javed R, Dinesh A. Epidemiology of cervical
cancer with special focus on India. Int J Women’s Health2015;
:405‑14.
Ernst & Young. Call for Action: Expanding cancer care
in India; 2018. Available from: https://www.ey.com/
Publication/vwLUAssets/EY‑Call‑for‑action‑expanding
cancer‑care‑in‑India. [Last accessed on 2025 April 11].
Lowy DR, Schiller JT. Reducing HPV-associated cancer
globally. Cancer Prev Res (Phila). 2012; 5:18-23.
Das BC, Gopalkrishna V, Sharma JK, Roy M, Luthra
UK. Human papillomavirus DNA in urine of women with
preneoplastic and neoplastic cervical lesions. Lancet (London,
England). 1992; 340: 1417±8. Available: http://www.ncbi.
nlm.nih.gov/pubmed/1360129
Pillai RM et al. Region-wise distribution of high-risk human
papillomavirus types in squamous cell carcinomas of the
cervix in India. Int J Gynecol Cancer. 2010; 20: 1046-51.
Kerkar SC, Latta S, Salvi V, Mania-Pramanik J. Human
Papillomavirus infection in asymptomatic population.
SexReprodHealthc. 2011; 2: 7-11.
Das BC, Gopalkrishna V, Hedau S K S. Cancer of the Uterine
Cervix and Human Papilloma viruses. Curr Sci. 2000;
(1):52-63.
Braaten KP, Laufer MR. Human papillomavirus (HPV), HPVrelated
disease, and the HPV vaccine. Rev Obstet Gynecol.
; 1:2–10.
WoodhallSC,LehtinenM,VerhoT,HuhtalaH, Hokkanen
M,KosunenE.Anticipatedacceptanceof HPV vaccination at
the baseline of implementation: a survey of parental and
adolescent knowledge and attitudes in Finland. J Adolesc
Health. 2007; 40: 466–9.
Sankaranarayannan R, Bhatla N, Basu P. Current global status
& impact of human papillomavirus vaccination: Implications
for India. Indian J Med Res 2016; 144:169‑80.
Indian Academy of Pediatrics Committee on Vaccines and
Immunization Practices (IAP COVI) Cervical cancer and
HPV vaccines; 2020. Available from: http://acvip.org/parents/
columns/cervical‑cancer.php.
World Health Organization. Immunizations, vaccines
and biologicals: human papillomavirus (HPV). Geneva:
WHO;2016 [cited 2025 Mar]. Available from: http://www.
who.int/immunization/diseases/hpv/en/.
Rashid S, Labani S, Das BC. Knowledge, awareness and
attitude on HPV, HPV vaccine and cervical cancer among
the college students in India. PloS One.2016;11:e0166713.
Rodriguez AM et al. Human papillomavirus vaccine
interventions in the U.S.: a systematic review and metanalysis.
Am J Prev Med. 2019:1–12.
Arunachalam D, Chandrabose GS. Knowledge and attitude
on human papilloma virus among adolescent girls in school
students at Puducherry. Int J Community Med Public Health.
;6(2):573-8.
Ansari N, Shaiju B, Hashmi S. A Pre-Experimental Study to
Assess the Effectiveness of Structured Teaching Programme
(STP) in Terms of Awareness of Female Students Regarding
Human Papillomavirus (HPV) and its Vaccine in a Selected
School of New Delhi. Chettinad Health City Med J.
;13(3):5-12.
Tripathy S, Mohapatra S, Muthulakshmi M, Rani R.
Knowledge, attitude towards human papillomavirus and HPV
vaccine among medical students of a tertiary care teaching
hospital in India. Int J Reprod Contracept Obstet Gynecol.
; 4:1771–1774.
Hussain S et al . Perception of human papillomavirus
infection, cervical cancer and HPV vaccination in North
Indian population. PLoS One. 2014 Nov 11;9(11): e112861.
Rao S, Kulkarni V, Patil S. Effect of health education on
awareness of HPV vaccination among healthcare students.
Indian J Health Sci Biomed Res. 2024;17(3):312-318.
Wang W, Sawleshwarkar S, Piraveenan M. Prevention
strategies and vaccination in human papillomavirus infection:
A systematic review. ComputEpidemiol. 2024.
Alqahtani M, Alharbi A, Alzahrani R. The effect of educational
intervention on HPV knowledge among college students.
Medicina. 2024;60(8):1276.
Li W, Jin Y, Li X, Jin M. Human papillomavirus and vaccine
knowledge, willingness, and uptake among university
students: a systematic review and meta-analysis. BMC Public
Health. 2025 Dec 19;25(1):4268.
Gilkey MB, McRee AL. Provider communication about HPV
vaccination: a systematic review. Hum VaccinImmunother.
;12(6):1454-1468.
Krawczyk A, Perez S, King L, et al. Parents’ decision-making
about the HPV vaccine for their daughters: systematic review
and meta-analysis. J Med Internet Res. 2015;17(8):e197.
World Health Organization. Human papillomavirus vaccines:
WHO position paper. WklyEpidemiol Rec. 2022;97(50):645-
Karafillakis E, Larson HJ. The benefit of the doubt or doubts
over benefits? A systematic literature review of perceived risks
of vaccines. Vaccine. 2017;35(37):4840-4850.
Dubé E, Laberge C, Guay M, et al. Vaccine hesitancy: an
overview. Hum VaccinImmunother. 2013;9(8):1763-1773.
doi:10.4161/hv.24657
Gee J, Naleway A, Shui I, et al. Monitoring the safety of
quadrivalent HPV vaccine. Vaccine. 2011;29(46):8279-8284.
Sung H, Ferlay J, Siegel RL, et al. Global cancer statistics
: GLOBOCAN estimates of incidence and mortality. CA
Cancer J Clin. 2021;71(3):209-249.
Downloads
Published
How to Cite
Issue
Section
License
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
